vs
爱德华生命科学（EW）与利氏兄弟拍卖行（RBA）财务数据对比。点击上方公司名可切换其他公司
爱德华生命科学的季度营收约是利氏兄弟拍卖行的1.4倍（$1.6B vs $1.2B），爱德华生命科学净利率更高（23.1% vs 9.1%，领先14.0%），爱德华生命科学同比增速更快（16.7% vs 5.4%），过去两年爱德华生命科学的营收复合增速更高（9.7% vs 6.3%）
爱德华生命科学是总部位于美国加利福尼亚州尔湾的医疗科技企业，专注于人工心脏瓣膜及血流动力学监测领域，其研发的Sapien经导管主动脉心脏瓣膜采用牛组织材质，搭配球囊扩张式钴铬合金支架，可通过导管完成植入。
利氏兄弟拍卖行（股票代码RBA）是全球知名的工业资产拍卖服务商，注册地位于加拿大，属公开上市企业，总部设在美国伊利诺伊州韦斯特切斯特，普通股同时在多伦多证券交易所与纽约证券交易所挂牌交易。
EW vs RBA — 直观对比
营收规模更大
EW
是对方的1.4倍
$1.2B
营收增速更快
EW
高出11.3%
5.4%
净利率更高
EW
高出14.0%
9.1%
两年增速更快
EW
近两年复合增速
6.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $1.2B |
| 净利润 | $380.7M | $109.7M |
| 毛利率 | 78.0% | — |
| 营业利润率 | 1.8% | 14.7% |
| 净利率 | 23.1% | 9.1% |
| 营收同比 | 16.7% | 5.4% |
| 净利润同比 | 6.8% | -7.4% |
| 每股收益（稀释后） | $0.66 | $0.53 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EWRBA
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $1.2B | ||
| Q3 25 | $1.6B | $1.1B | ||
| Q2 25 | $1.5B | $1.2B | ||
| Q1 25 | $1.4B | $1.1B | ||
| Q4 24 | $1.4B | $1.1B | ||
| Q3 24 | $1.4B | $981.8M | ||
| Q2 24 | $1.4B | $1.1B |
净利润EWRBA
| Q1 26 | $380.7M | — | ||
| Q4 25 | $91.2M | $109.7M | ||
| Q3 25 | $291.1M | $95.5M | ||
| Q2 25 | $333.2M | $109.8M | ||
| Q1 25 | $358.0M | $113.4M | ||
| Q4 24 | $385.6M | $118.5M | ||
| Q3 24 | $3.1B | $76.1M | ||
| Q2 24 | $366.3M | $111.1M |
毛利率EWRBA
| Q1 26 | 78.0% | — | ||
| Q4 25 | 78.1% | — | ||
| Q3 25 | 77.8% | — | ||
| Q2 25 | 77.5% | — | ||
| Q1 25 | 78.7% | — | ||
| Q4 24 | 78.9% | — | ||
| Q3 24 | 80.6% | — | ||
| Q2 24 | 79.9% | — |
营业利润率EWRBA
| Q1 26 | 1.8% | — | ||
| Q4 25 | 9.6% | 14.7% | ||
| Q3 25 | 19.8% | 14.5% | ||
| Q2 25 | 26.8% | 15.9% | ||
| Q1 25 | 27.9% | 17.1% | ||
| Q4 24 | 22.6% | 18.1% | ||
| Q3 24 | 25.9% | 15.6% | ||
| Q2 24 | 26.8% | 18.4% |
净利率EWRBA
| Q1 26 | 23.1% | — | ||
| Q4 25 | 5.8% | 9.1% | ||
| Q3 25 | 18.7% | 8.7% | ||
| Q2 25 | 21.7% | 9.3% | ||
| Q1 25 | 25.3% | 10.2% | ||
| Q4 24 | 27.8% | 10.4% | ||
| Q3 24 | 226.7% | 7.8% | ||
| Q2 24 | 26.7% | 10.1% |
每股收益（稀释后）EWRBA
| Q1 26 | $0.66 | — | ||
| Q4 25 | $0.16 | $0.53 | ||
| Q3 25 | $0.50 | $0.43 | ||
| Q2 25 | $0.56 | $0.53 | ||
| Q1 25 | $0.61 | $0.55 | ||
| Q4 24 | $0.65 | $0.58 | ||
| Q3 24 | $5.13 | $0.36 | ||
| Q2 24 | $0.61 | $0.54 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $531.5M |
| 总债务越低越好 | — | $2.3B |
| 股东权益账面价值 | — | $5.6B |
| 总资产 | — | $12.1B |
| 负债/权益比越低杠杆越低 | — | 0.42× |
8季度趋势，按日历期对齐
现金及短期投资EWRBA
| Q1 26 | — | — | ||
| Q4 25 | $4.2B | $531.5M | ||
| Q3 25 | $3.8B | $674.7M | ||
| Q2 25 | $4.1B | $710.2M | ||
| Q1 25 | $3.9B | $578.1M | ||
| Q4 24 | $4.0B | $533.9M | ||
| Q3 24 | $4.4B | $650.7M | ||
| Q2 24 | $2.0B | $599.5M |
总债务EWRBA
| Q1 26 | — | — | ||
| Q4 25 | — | $2.3B | ||
| Q3 25 | — | $2.6B | ||
| Q2 25 | — | $2.6B | ||
| Q1 25 | — | $2.6B | ||
| Q4 24 | — | $2.6B | ||
| Q3 24 | — | $2.7B | ||
| Q2 24 | — | $2.8B |
股东权益EWRBA
| Q1 26 | — | — | ||
| Q4 25 | $10.3B | $5.6B | ||
| Q3 25 | $10.2B | $5.5B | ||
| Q2 25 | $10.5B | $5.5B | ||
| Q1 25 | $10.1B | $5.3B | ||
| Q4 24 | $10.0B | $5.2B | ||
| Q3 24 | $9.5B | $5.2B | ||
| Q2 24 | $7.4B | $5.2B |
总资产EWRBA
| Q1 26 | — | — | ||
| Q4 25 | $13.7B | $12.1B | ||
| Q3 25 | $13.3B | $12.2B | ||
| Q2 25 | $13.5B | $12.2B | ||
| Q1 25 | $13.0B | $11.9B | ||
| Q4 24 | $13.1B | $11.8B | ||
| Q3 24 | $13.0B | $11.9B | ||
| Q2 24 | $10.1B | $12.1B |
负债/权益比EWRBA
| Q1 26 | — | — | ||
| Q4 25 | — | 0.42× | ||
| Q3 25 | — | 0.47× | ||
| Q2 25 | — | 0.47× | ||
| Q1 25 | — | 0.50× | ||
| Q4 24 | — | 0.50× | ||
| Q3 24 | — | 0.52× | ||
| Q2 24 | — | 0.55× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $255.2M |
| 自由现金流经营现金流 - 资本支出 | — | $186.5M |
| 自由现金流率自由现金流/营收 | — | 15.5% |
| 资本支出强度资本支出/营收 | — | 5.7% |
| 现金转化率经营现金流/净利润 | — | 2.33× |
| 过去12个月自由现金流最近4个季度 | — | $719.2M |
8季度趋势，按日历期对齐
经营现金流EWRBA
| Q1 26 | — | — | ||
| Q4 25 | $450.9M | $255.2M | ||
| Q3 25 | $573.7M | $239.7M | ||
| Q2 25 | $290.2M | $326.5M | ||
| Q1 25 | $280.4M | $156.8M | ||
| Q4 24 | $-127.5M | $184.5M | ||
| Q3 24 | $351.8M | $285.4M | ||
| Q2 24 | $371.5M | $337.3M |
自由现金流EWRBA
| Q1 26 | — | — | ||
| Q4 25 | $353.5M | $186.5M | ||
| Q3 25 | $516.2M | $188.5M | ||
| Q2 25 | $240.9M | $241.7M | ||
| Q1 25 | $224.4M | $102.5M | ||
| Q4 24 | $-177.3M | $127.9M | ||
| Q3 24 | $299.9M | $248.5M | ||
| Q2 24 | $286.1M | $308.6M |
自由现金流率EWRBA
| Q1 26 | — | — | ||
| Q4 25 | 22.5% | 15.5% | ||
| Q3 25 | 33.2% | 17.3% | ||
| Q2 25 | 15.7% | 20.4% | ||
| Q1 25 | 15.9% | 9.2% | ||
| Q4 24 | -12.8% | 11.2% | ||
| Q3 24 | 22.1% | 25.3% | ||
| Q2 24 | 20.9% | 28.2% |
资本支出强度EWRBA
| Q1 26 | — | — | ||
| Q4 25 | 6.2% | 5.7% | ||
| Q3 25 | 3.7% | 4.7% | ||
| Q2 25 | 3.2% | 7.2% | ||
| Q1 25 | 4.0% | 4.9% | ||
| Q4 24 | 3.6% | 5.0% | ||
| Q3 24 | 3.8% | 3.8% | ||
| Q2 24 | 6.2% | 2.6% |
现金转化率EWRBA
| Q1 26 | — | — | ||
| Q4 25 | 4.94× | 2.33× | ||
| Q3 25 | 1.97× | 2.51× | ||
| Q2 25 | 0.87× | 2.97× | ||
| Q1 25 | 0.78× | 1.38× | ||
| Q4 24 | -0.33× | 1.56× | ||
| Q3 24 | 0.11× | 3.75× | ||
| Q2 24 | 1.01× | 3.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EW
暂无分部数据
RBA
| Buyer Revenue | $577.2M | 48% |
| Seller Revenue | $255.2M | 21% |
| CA | $199.0M | 17% |
| Other | $124.7M | 10% |
| AU | $47.3M | 4% |
